Mazdutide 10mg x 10 Vials
$241.07
Mazdutide 10mg x 10 Vials. Mazdutide, also known by the development designation IBI362, is a chemically modified peptide investigated in GLP-1 and glucagon receptor systems. Its full molecular specification includes the peptide component and its attached modification. Reference chemistry is useful for molecular comparison but does not certify the identity or quality of a supplied vial. Pack: 10 vials. 10 mg per vial; 100 mg nominal total across 10 vials. Intended exclusively for controlled in vitro laboratory research; not for human or veterinary use.
Mazdutide 10mg Australia — 10-Vial Research Kit
Buy Mazdutide 10mg in Australia through AU Peptides Shop’s research catalogue. This listing is a kit of 10 vials. The stated strength applies to each vial, with the kit quantity shown separately below. It is supplied exclusively for controlled in vitro laboratory research and analytical evaluation.
Product description
Mazdutide, also known by the development designation IBI362, is a chemically modified peptide investigated in GLP-1 and glucagon receptor systems. Its full molecular specification includes the peptide component and its attached modification. Reference chemistry is useful for molecular comparison but does not certify the identity or quality of a supplied vial.
Mazdutide and Survodutide are distinct peptide entities. They should retain separate identity records, reference standards and analytical specifications. Similar receptor-research terminology does not establish that their sequences, modifications or sample behaviour are the same.
Product and chemical information
| Product name | Mazdutide 10mg x 10 Vials |
|---|---|
| Pack size | 10 vials per kit |
| Labelled quantity | 10 mg per vial; 100 mg nominal total across 10 vials |
| Research presentation | Vials; confirm batch-specific physical form |
| Reference sequence / construct | Refer to the sequence, construct and terminal-group specification for the supplied material. |
| Molecular reference | Mazdutide |
| Reference molecular formula | C207H317N45O65 |
| Reference molecular weight | 4476 g/mol |
For a molecular-reference comparison, view the reference structure in PubChem. Reference chemistry describes the named database species, not an analytical certificate for a supplied batch. Counterions, hydration and formulation ingredients may change the relationship between that reference and the material in a vial.
Understanding the 10-vial kit
The labelled kit specification is 10 mg per vial; 100 mg nominal total across 10 vials. Each vial remains a separate container for sample traceability. The total kit amount is a nominal sum of the per-vial labels; it is not a concentration and does not specify a solvent volume. Keep the selected strength in your purchase record so that this entry is distinguished from other Mazdutide strengths.
A milligram label identifies nominal material quantity. It does not independently establish assay content, chromatographic purity or the amount of peptide base after accounting for counterions and water. For a quantitative experiment, compare the label with the applicable content-assay report and record the basis used to express the result.
Research applications
- Modified-peptide characterisation.
- Comparative receptor-system studies in vitro.
- Stability-indicating analytical methods.
- Assessment of finished-sample recovery.
These applications describe laboratory questions and methods. They do not establish a biological result for this particular batch or support human administration. Select a defined experimental model and include controls that distinguish the material response from effects of the vehicle, assay matrix and any other formulation ingredients.
Analytical evaluation
For Mazdutide, separate intact-molecule identification from measurement of labelled content. A compatible molecular mass is one part of an identity assessment, while chromatographic resolution provides different information about related species. Use a matching reference material and retain the specified modification when comparing peptide maps or other structural records.
Identity, content and purity are separate attributes. A peak-area percentage alone does not prove sequence identity, vial fill quantity or sterility. Retain the batch identifier, method, reference material and reporting basis with any result. Where acceptance criteria depend on a particular attribute, obtain evidence for that attribute rather than infer it from a general research-grade label.
Storage and laboratory handling
Follow the storage and handling conditions documented for the supplied Mazdutide 10mg batch. A universal freezer temperature or prepared-sample expiry cannot be established from a product name alone. Keep containers traceable to their batch records, protect material from unsuitable environmental exposure and record handling events that could affect the analytical comparison.
The shared catalogue image is a representative vial-kit illustration. It does not confirm the actual physical appearance, packaging details or analytical properties of an individual batch. Likewise, a vial is a container format and does not itself prove lyophilisation, a particular solution composition or sterility. Use the supplied specification for the actual material.
Compare research products in Australia
Compare the exact sequence or construct, per-vial strength and kit size before choosing another listing. Related catalogue entries may represent different compounds, modified forms or quantities. Browse the research peptide vials category or the complete research catalogue for individually specified products.
Buying Mazdutide 10mg in Australia
This Mazdutide 10mg x 10 Vials listing identifies the material and pack format for an Australian research purchase. The purchasing area shows the current kit price in the store’s configured currency. For documentation enquiries, include the complete product name and strength when you contact AU Peptides Shop. Confirm the required batch evidence before relying on a catalogue specification in a laboratory protocol.
Research documentation
For a reproducible record, keep the purchase specification, batch identifier and analytical report together. Record whether the reported amount is nominal fill, peptide content or an activity-based result. If a study compares two strengths, identify the concentration and measurement basis independently of the package size. A change in vial strength does not by itself establish a difference in molecular identity or product quality.
Scientific references
Research-use notice
For controlled in vitro laboratory research only. Not for human or veterinary use. This page provides catalogue and scientific-reference information. It does not provide dosing, administration or treatment instructions, and a research-use label does not establish approval for a medical application.
Additional information
| Pack size | 10 vials |
|---|---|
| Labelled strength | 10 mg per vial; 100 mg nominal total across 10 vials |




